Abstract:Objective To evaluate the clinical value of contrast enhanced uhrasound(CEUS)for uhrasoundguided radiofrequency ablation(RFA)of liver metastasis.Methods One hundred and forty-one consecutive patients with liver metastasis asked for RFA treatment in our department.Of them,102 patients with received CEUS with SonoVue before RFA treatment.Eighty-six of the 102 patients were regarded as indications for RFA by CEUS(Group A).During the same period,another 39 patients who received conventional US without contrast before RFA were served as the control group(Group B).In Group A,the RFA protocol for each case was designed according to CEUS finding,which included perfusion feature,lesion number,size,shape,invasive range,location and relationship between tumor and surrounding structures.In Group B.the RFA protocol for each case was designed according to conventional ultrasound and CT/MRI result.Results In 102 patients who intended to receive RFA treatment,1 6 were excluded from RFA after CEUS examination.Of them,3 patients with 10 tumors received 6-10 sessions of chemotherapy and there were no enhancement within or around tumors.Another 13 cases were found that the invasive range being more than 8 cm in size,tumor number more than 7,and tumor location adhered to diaphragm and second hepatic helium by CEUS.In Grou0 A,CEUS detected additional 1-3 tumors in 36 patients(41.9%).The size range of the 58 new tumors was 8-15 mm.Of these,79.4%(46/58 tumors)were visualized in parenchymal phase.A total of 209 liver metastasis tumors were treated by RFA.CEUS before RFA demonstrated 49.7%(75/151 tumors)were 1arger in size compared with conventional US.Of these,69.3%(52/75 tumors)presented larger in arterial phase,the remaining 30.7%(23/75 tumors)presented larger in parenchymal phase,and the increased area was also ablated.On 1-3 months follow up with CT,the tumor necrosisrate in Group A was 94.7%(198/209 tumors),which was significantly higher than 87.6%(99/113 tumors)in Group B ( P=0.013). During follow-up period, local recurrence were found in 15 tumors (7.1 %) 2-17 months after REA and intrahepatic new tumors developed in 32 patients (37.2%) 2-17 months after RFA in group A,While local recurrence were found in 16 tumors (14.1%) and intrahepatic new tumors developed in 17 patients (43.5%) in group B ( P=0. 041, P ＞0.05, respectively). Conclusions CEUS provides important information for selecting candidation and designing optimal protocol for RFA in liver metastasis. The use of CEUS can increase tumor necrosis rate and decrease post-RFA tumor local recurrence,and then improve efficacy of RFA therapy.

CLINICAL APPLICATION OF CONTRAST-ENHANCED ULTRASOUND USING HIGH-FREQUENCY LINEAR PROBE IN THE DETECTION OF SMALL COLORECTAL LIVER METASTASES

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Assessment of Liver Metastasis in Patients with Advanced Gastric Cancer Using Contrast-Enhanced Ultrasonography

Role of contrast-enhanced ultrasound for preoperative detection of colorectal liver metastases-compared with histopathologic results

Detection of Hepatic Metastases by Contrast-Enhanced Ultrasound Compared with Conventional Ultrasound and Contrast-Enhanced Computed Tomography

Clinical application of contrast-enhanced ultrasonography for malignant hepatic lesions undetected on conventional ultrasound

Detection and Characterization of Small Superficially Located Focal Liver Lesions by Contrast-Enhanced Ultrasound with High Frequency Transducers.

Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases

Clinical Value of Contrast-Enhanced Ultrasonography in the Characterization of Focal Liver Lesions: a Prospective Multicenter Trial.

A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis

Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases.

Clinical value of contrast-enhanced ultrasound versus conventional ultrasound in biopsy of focal liver lesions

Contrast-enhanced ultrasound for the differential diagnosis between benign and metastatic superficial lymph nodes: a meta-analysis

The Role of Contrast-Enhanced Ultrasound on the Diagnosis of Small Hepatocellular Carcinoma (≤3cm) in Patients with Cirrhosis

Comparison of Contrast‐enhanced Ultrasonography with Virtual Touch Tissue Quantification in the Evaluation of Focal Liver Lesions

Comparison Of Contrast-Enhanced Ultrasound And Contrast-Enhanced Helical Ct In The Diagnosis Of High Echo-Level Small Focal Liver Lesions

Diagnostic Performance of Contrast Enhanced CT Alone or in Combination with (Non-)Enhanced MRI for Colorectal Liver Metastasis.

Role of Contrast Enhanced Ultrasound in Radiofrequency Ablation of Metastatic Liver Carcinoma

Contrast-Enhanced Intraoperative Ultrasound Improved Sensitivity and Positive Predictive Value in Colorectal Liver Metastasis: a Systematic Review and Meta-Analysis

The role of contrast enhanced ultrasound in radiofrequency ablation of liver metastasis